Pacific Biosciences of California, Inc. Retained Earnings
Pacific Biosciences of California, Inc. (PACB) had Retained Earnings of -$2.75 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$2.75B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$2.70B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$2.70B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$2.65B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$2.75B 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$2.70B 10-Q · filed 2026-05-08 |
| 2025-12-31 | -$2.70B 10-Q · filed 2026-08-06 |
| 2025-09-30 | -$2.65B 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$2.62B 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$2.58B 10-Q · filed 2025-05-12 |
| 2024-12-31 | -$2.15B 10-K · filed 2026-02-25 |
| 2024-09-30 | -$2.15B 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$2.09B 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$1.92B 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$1.84B 10-K · filed 2025-03-17 |
| 2023-09-30 | -$1.76B 10-Q · filed 2023-11-03 |
| 2023-06-30 | -$1.69B 10-Q · filed 2023-08-04 |
| 2023-03-31 | -$1.62B 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$1.53B 10-K · filed 2024-02-28 |
| 2022-09-30 | -$1.45B 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$1.37B 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$1.30B 10-Q · filed 2022-05-06 |
| 2021-12-31 | -$1.22B 10-K · filed 2023-02-28 |
| 2021-09-30 | -$1.15B 10-Q · filed 2021-11-05 |
| 2021-06-30 | -$1.17B 10-Q · filed 2021-08-06 |
| 2021-03-31 | -$1.12B 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$1.04B 10-K · filed 2022-02-28 |
| 2020-09-30 | -$1.11B 10-Q · filed 2020-11-03 |
| 2020-06-30 | -$1.09B 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$1.07B 10-Q · filed 2020-05-08 |
| 2020-01-01 | -$1.07B 10-Q · filed 2020-11-03 |
| 2019-12-31 | -$1.07B 10-K · filed 2021-02-26 |
| 2019-09-30 | -$1.07B 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$1.04B 10-Q · filed 2019-08-06 |
| 2019-03-31 | -$1.01B 10-Q · filed 2019-05-03 |
| 2018-12-31 | -$982.11M 10-K · filed 2020-02-28 |
| 2018-09-30 | -$951.31M 10-Q · filed 2018-11-05 |
| 2018-06-30 | -$926.26M 10-Q · filed 2018-08-03 |
| 2018-03-31 | -$903.72M 10-Q · filed 2018-05-02 |
| 2018-01-01 | -$879.54M 10-K · filed 2019-02-26 |
| 2017-12-31 | -$879.73M 10-K · filed 2019-02-26 |
| 2017-09-30 | -$858.97M 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$836.95M 10-Q · filed 2017-08-02 |
| 2017-03-31 | -$811.41M 10-Q · filed 2017-05-05 |
| 2016-12-31 | -$787.54M 10-K · filed 2018-02-26 |
| 2016-09-30 | -$768.51M 10-Q · filed 2016-11-04 |
| 2016-06-30 | -$751.02M 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$732.52M 10-Q · filed 2016-05-05 |
| 2015-12-31 | -$713.17M 10-K · filed 2017-03-06 |
| 2015-09-30 | -$711.76M 10-Q · filed 2015-11-05 |
| 2015-06-30 | -$713.58M 10-Q · filed 2015-08-05 |
| 2015-03-31 | -$701.65M 10-Q · filed 2015-05-05 |
| 2014-12-31 | -$681.47M 10-K · filed 2016-03-11 |
| 2014-09-30 | -$662.50M 10-Q · filed 2014-11-05 |
| 2014-06-30 | -$653.34M 10-Q · filed 2014-08-05 |
| 2014-03-31 | -$634.20M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$615.31M 10-K · filed 2015-03-12 |
| 2013-09-30 | -$598.08M 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$577.60M 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$557.12M 10-Q · filed 2013-05-10 |
| 2012-12-31 | -$536.02M 10-K · filed 2014-03-14 |
| 2012-09-30 | -$514.35M 10-Q · filed 2012-11-01 |
| 2012-06-30 | -$491.62M 10-Q · filed 2012-08-07 |
| 2012-03-31 | -$469.13M 10-Q · filed 2012-05-07 |
| 2011-12-31 | -$441.56M 10-K · filed 2013-03-15 |
| 2011-09-30 | -$418.73M 10-Q · filed 2011-11-14 |
| 2011-06-30 | -$389.45M 10-Q · filed 2011-08-12 |
| 2010-12-31 | -$332.17M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |